Bill Snyder

From left, Jennifer Herington, PhD, Jeff Reese, MD, Elaine Shelton, PhD, and Shajila Siricilla, PhD, are studying whether drugs given to premature infants in the NICU contribute to patent ductus arteriosus.
August 18, 2022

Study seeks to explore drug link to fetal vessel defect

Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.

By Bill Snyder
August 17, 2022

Vanderbilt Prize winner Lehmann’s Discovery Lecture postponed

Ruth Lehmann, PhD, recipient of the 2022 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, Sept. 1, in 208 Light Hall.

By Bill Snyder
August 16, 2022

Nanoparticles boost anti-cancer immunity

An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.

By Bill Snyder
August 3, 2022

VUMC’s Aspirnaut program celebrates 15th anniversary, and NBC News returned to highlight its students

A link to the video story and an inside look at the taping and some of this year’s participants

By Bill Snyder
Eighteen high school students and 16 college undergraduates participated in the Aspirnaut program this summer. Program co-founders Billy Hudson, PhD, and Julie Hudson, MD, MA, are at far left and right. Fourth from right, back row, is Aspirnaut alumna Lauren Taylor, from Grapevine, Arkansas, who participated in the inaugural Aspirnaut program 15 years ago — a broadband internet-equipped school bus the Hudsons dubbed their “mobile one-room schoolhouse,” which enabled students to log into science and math lessons during their long bus rides to and from school.
August 3, 2022

Science career “pipeline” garners national attention

Vanderbilt’s Aspirnaut STEM pipeline for diversity and wellness recently celebrated its 15th anniversary with a daylong scientific symposium, followed by a feature on the program broadcast Aug. 2 on NBC Nightly News.

By Bill Snyder
August 3, 2022

Embryo screening for mental illness questioned

Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life.

By Bill Snyder
July 28, 2022

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
By Bill Snyder
July 28, 2022

C. difficile may contribute to colorectal cancer: study

A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.
By Bill Snyder
July 21, 2022

Researchers find potential new target against colorectal cancer

By Bill Snyder
July 21, 2022

Difficulty swallowing linked to chronic opioid use: study

Vanderbilt researchers found that chronic use of opioid painkillers like hydrocodone and oxycodone significantly increases the risk of dysphagia, or difficulty swallowing.
By Bill Snyder
July 21, 2022

Longtime division leader earns degree, accolades

Vanderbilt's Amy Shelton, MS, has been awarded a Master of Science Degree in Research Administration with Honors from the Johns Hopkins University Krieger School of Arts and Sciences.
By Bill Snyder
July 14, 2022

Vanderbilt MSTP students receive P.E.O. Scholar Awards

Three aspiring physician-scientists in Vanderbilt University’s Medical Scientist Training Program are among this year’s recipients of highly competitive P.E.O. Scholar Awards.
By Bill Snyder
1 … 20 21 22 23 24 … 115